V. Naik, A. Darandale, and P. Pal, “Emerging Role of SGLT2 Inhibitors Beyond Glycemic Control: ‘Cardiovascular and Renal Benefits and Risks’”, CARDIO , vol. 1, no. 1, pp. 29–38, Mar. 2026, doi: 10.64229/v3v43h95.